United States · FDA National Drug Code directory
Loargys
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81583-102_d5ceabf2-43a0-4746-9371-d98a39cf6cfc
- Product NDC
- 81583-102
- Form
- INJECTION
- Composition / generic term
- pegzilarginase-nbln
- Labeler
- Immedica Pharma US Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260309
- Source listing expiry
- 20271231
Source-listed ingredients
- PEGZILARGINASE — 2 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (81583-102-01) / .4 mL in 1 VIAL · 81583-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →